Summary
- Current Price
- As of today, AIDX price is $2.17, up +0.46% in the most recent trading session on
- Current Price All-Time High
- AIDX price is currently -95.66% below its historical high of $50.00 set on
- Market Cap
- AIDX current market cap is $22M, with unknown 1-year change
- PE Ratio
- AIDX PE ratio is unknown
- Revenue
- AIDX current annual revenue is $1.75M, up +23.03% year-over-year
- Next Earnings
- As of today, the next earnings release for AIDX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | 20/20 Biolabs, Inc. |
| Ticker | NASDAQ: AIDX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | 2020biolabs.com |
| Employees | 13 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.17 | ||
| Price, 1D Change | +0.46% | |
| $22M | ||
| - | ||
| - | ||
| 0.41 | ||
| $2M | ||
| Revenue, 1Y Change | +23.03% | |
| -$1.16 | ||
| EPS, 1Y Change | +13.43% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.16 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $1.75M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $2.17 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
No EPS data available
Revenue
No revenue data available
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +23.03% | ||
| -81.79% | ||
| +13.43% | ||
| -627.27% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.17 | ||
| $5.48 | ||
| SMA 200 vs Price | +152.53% | |
| $5.48 | ||
| SMA 50 vs Price | +152.53% | |
| 0.41 | ||
| $1.45 | ||
| 3.42 | ||
| 120.44% | ||
| 212.85% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.75M | ||
| -$1.16 | ||
| $360.30K | ||
| 20.56% | ||
| -$5.66M | ||
| -323.07% | ||
| -$5.55M | ||
| -316.82% | ||
| -$5.53M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.55 | ||
| 1.50 | ||
| 1.47 | ||
| - | ||
| - | ||
| -9.41 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 23.53 | ||
| 366.29 | ||
| -11.27 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.49M | ||
| $1.78M | ||
| $3.61M | ||
| $2.03M | ||
| $2.08M | ||
| $1.36M | ||
| $839.60K | ||
| $165.70K | ||
| $372.30K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $7.30M | ||
| $6.02M | ||
| $1.39M | ||
| $4.76M | ||
| $135.80K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$2.60M | ||
| $0.00 | ||
| $293.30K | ||
| $0.00 | ||
| -$2.60M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| No data | N/A | N/A |
Analyst sentiment
Institutional ownership
Screeners with AIDX
FAQ
What is the ticker symbol for 20/20 Biolabs, Inc.?
The ticker symbol for 20/20 Biolabs, Inc. is NASDAQ:AIDX
Does 20/20 Biolabs, Inc. pay dividends?
No, 20/20 Biolabs, Inc. does not pay dividends
What sector is 20/20 Biolabs, Inc. in?
20/20 Biolabs, Inc. is in the Healthcare sector
What industry is 20/20 Biolabs, Inc. in?
20/20 Biolabs, Inc. is in the Medical Devices industry
What country is 20/20 Biolabs, Inc. based in?
20/20 Biolabs, Inc. is headquartered in United States
When did 20/20 Biolabs, Inc. go public?
20/20 Biolabs, Inc. initial public offering (IPO) was on June 15, 2023
Is 20/20 Biolabs, Inc. in the S&P 500?
No, 20/20 Biolabs, Inc. is not included in the S&P 500 index
Is 20/20 Biolabs, Inc. in the NASDAQ 100?
No, 20/20 Biolabs, Inc. is not included in the NASDAQ 100 index
Is 20/20 Biolabs, Inc. in the Dow Jones?
No, 20/20 Biolabs, Inc. is not included in the Dow Jones index
When does 20/20 Biolabs, Inc. report earnings?
The date for 20/20 Biolabs, Inc.'s next earnings report has not been announced yet
Data Sources & References
- AIDX Official Website 2020biolabs.com
- AIDX Profile on Yahoo Finance finance.yahoo.com/quote/AIDX
- AIDX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aidx